Related Experiment Videos

Cobalt-55 positron emission tomography in relapsing-progressive multiple sclerosis

H M Jansen1, A T Willemsen, L G Sinnige

  • 1Department of Neurology, University Hospital Groningen, Netherlands.

Insights

Cobalt-55 (Co-55) Positron Emission Tomography (PET) detects more lesions in progressive multiple sclerosis (MS) brains than healthy brains. Co-55 PET lesion frequency correlates with MS disease progression rate.

Area of Science:

  • Neuroscience
  • Radiology
  • Immunology

Background:

  • Multiple sclerosis (MS) is an immune-mediated brain disease characterized by white matter damage.
  • Relapsing-progressive MS (RP-MS) involves neuronal and oligodendrocyte decay, leading to structural brain loss and disability.
  • Calcium (Ca) influx is critical in cell death and T-lymphocyte activation in MS.

Purpose of the Study:

  • To evaluate Cobalt-55 (Co-55) Positron Emission Tomography (PET) as a tool for detecting lesions in RP-MS.
  • To assess the correlation between Co-55 PET detected lesions, MS progression rate (PR), and MRI findings.

Main Methods:

  • Seven RP-MS patients and seven healthy controls underwent both MRI and Co-55 PET scans.
  • Co-55 was used as a calcium tracer to visualize brain tissue damage.
  • Image modalities were merged for comparison, and Co-55 PET lesion frequency was correlated with PR.

Main Results:

  • Co-55 PET revealed significantly more lesions in RP-MS brains compared to healthy controls, including periventricular and cortical lesions.
  • All lesions detected by MRI were also identifiable by Co-55 PET.
  • A significant correlation was found between Co-55 PET lesion frequency and the PR of MS.

Conclusions:

  • Co-55 PET shows promise in detecting brain tissue damage in RP-MS.
  • The technique may serve as a valuable tool for estimating disease activity and progression in RP-MS.

Related Concept Videos